USC to Merge with Scripps?

Rumors are swirling that the University of Southern California may acquire The Scripps Research Institute.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Julian Voss-Andreae's "Angel of the West" adorns the campus of The Scripps Research Institute FloridaWIKIMEDIA, JULIANVAThe University of Southern California may acquire or merge with the Scripps Research Institute, according to unnamed Scripps researchers who spoke with the San Diego Union-Times, which broke the story. The private institutions themselves were less specific about a possible move. “The University of Southern California (USC) and The Scripps Research Institute (TSRI) are discussing the possibility of a relationship that would enhance the missions of both institutions,” Michael Marletta, president and CEO of TSRI, and Elizabeth Garrett, USC provost and senior vice president for academic affairs, said in a joint statement. “TSRI and USC have a shared commitment to academic excellence that will result in meaningful breakthroughs to improve health and well-being.”

Such a merger would be virtually unprecedented. “I’ve never heard of quite anything like this,” medicinal chemist Derek Lowe told the Union-Times. “It’s not like universities do this. You don’t hear that Penn is taking over Penn State in a corporate merger.”

The La Jolla, California-based TSRI, which specializes in chemistry, stem cell research, and molecular biology, announced an expansion into Florida in 2003, with a campus in Jupiter. The Sunshine State offered TSRI hundreds of millions of dollars in incentives to open shop in Palm Beach County. The news that USC and TSRI are negotiating some sort of joint relationship has angered at least one Florida politician. “I am outraged by this announcement and find it unacceptable based on several factors, including a recent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies